Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Department of Neonatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
J Pharm Biomed Anal. 2023 Jan 20;223:115148. doi: 10.1016/j.jpba.2022.115148. Epub 2022 Nov 7.
Short chain fatty acids (SCFAs), crucial intestinal bacterial metabolites, have been widely accepted as potential diagnostic markers in neonatal medicine. Nevertheless, it is still a great challenge to accurately quantify SCFAs in newborn fecal samples due to the huge variation of water content, limited commercial isotope-labeled internal standards and poor sensitivity. In this study, NaCO solution (50 μg/mL) was applied to convert the free SCFAs to SCFA sodium salts, which could prevent the loss of violate SCFAs during lyophilization process. Furthermore, N-methylbenzylamine-d/d was applied as the chemical derivatization regent to enhance the sensitivity and accuracy. Based on this method, the SCFA contents in meconium and neonatal fecal samples were analyzed to illustrate the change of SCFAs during the gut microbiome development. Chemical derivatization based on N-methylbenzylamine-d/d could not only significantly promote the sensitivity (323-1280 folds compared to free SCFAs) by promoting the ionization efficiency, but also provide one-to-one isotope internal standards. Moreover, 7 SCFAs, including acetic acid (2), n-butyric acid (4), isobutyric acid (5), 2-hydroxybutyric acid (11), 2-hydroxy-3-methylbutyric acid (13), 3-hydroxybutyric acid (14), 2-hydroxy-2-methylbutyric acid (17) were found to be significantly increased in neonatal fecal samples compared to the meconium fecal samples. All these results proved that this method could be applied for SCFA analysis in newborn fecal samples with perfect accuracy and sensitivity.
短链脂肪酸(SCFAs)是肠道细菌的重要代谢产物,已被广泛认为是新生儿医学中潜在的诊断标志物。然而,由于含水量的巨大变化、有限的商业同位素标记内标和较差的灵敏度,准确量化新生儿粪便样本中的 SCFAs 仍然是一个巨大的挑战。在这项研究中,应用 NaCO 溶液(50μg/mL)将游离 SCFAs 转化为 SCFA 钠盐,这可以防止冻干过程中挥发性 SCFAs 的损失。此外,应用 N-甲基苄胺-d/d 作为化学衍生试剂来提高灵敏度和准确性。基于该方法,分析胎粪和新生儿粪便样本中的 SCFA 含量,以说明肠道微生物组发育过程中 SCFA 的变化。基于 N-甲基苄胺-d/d 的化学衍生不仅可以通过促进离子化效率将灵敏度提高 323-1280 倍,而且还可以提供一对一的同位素内标。此外,与胎粪相比,在新生儿粪便样本中发现 7 种 SCFAs(包括乙酸(2)、正丁酸(4)、异丁酸(5)、2-羟基丁酸(11)、2-羟基-3-甲基丁酸(13)、3-羟基丁酸(14)、2-羟基-2-甲基丁酸(17))显著增加。所有这些结果都证明,该方法可用于新生儿粪便样本中 SCFA 的分析,具有完美的准确性和灵敏度。